Berlin - New therapeutic modalities are needed for treating thesubstantial population of acne patients with marked inflammatory diseaseand scarring. Available data indicate compounds with selective anti-inflammatoryactivity may help fill that niche, Christos C. Zouboulis, M.D., said.
